Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 11
- DOI:
- 10.3760/cma.j.issn.0366-6999.2010.11.010
- Key Word:
- Dickkopf-1 protein,human;osteoprotegerin;bone resorption;bone remodeling;arthritis,rheumatoid
Abstract： Background Rheumatoid arthritis (RA) is characterized by inflammation of the synovial membrane, leading to invasion of synovial tissue into the adjacent cartilage matrix with degradation of articular cartilage and bone as a consequence. Dickkopf-1 (DKK-1) and osteoprotegerin (OPG) have been demonstrated to be key molecules involved in bone erosion and bone remodeling. The aim of this study was to explore the potential role of DKK-1 and OPG in different stage of RA.Methods The protein levels of DKK-1 and OPG were detected by ELISA. The serum samples were collected from 300 patients with RA and 60 healthy controls. Of which, 150 RA patients were defined as early RA (disease duration ≤1 year), and other 150 RA patients were defined as longlasting RA (disease duration ≥5 years). At the time of serum sampling, various clinical and laboratory parameters were assessed. The correlations of DKK-1 or OPG and clinical/laboratory parameters were analyzed.Results The serum level of DKK-1 was elevated in patients with longstanding RA compared with healthy controls, while no significant difference was observed between the two groups in the level of OPG.In contrast, in early RA patients, the circulating OPG was elevated, while there was no significant difference between the two groups in expression of DKK-1. The serum DKK-1 was correlated with Sharp score and DAS28 in longstanding RA patients. In early RA, age was the only parameter that was significantly related to serum OPG.Conclusions There was a cross-talk between DKK-1 and OPG,which involved in bone destruction in RA. In different stage of RA, DKK-1 and OPG may play different roles in the pathogenesis of RA.
- [1]Delmas PD,Hofbauer LC,Roth S,etc.Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.[J].2001,86(7).
- [2]D, van Zeben,J M, Hazes,A H, Zwinderman,etc.Factors predicting outcome of rheumatoid arthritis: results of a followup study.[J].1993,20.
- [3]Van G,Sarosi I,Simonet WS,etc.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.[J].2000,192(4).
- [4]Atkinson EJ,Riggs BL,Melton LJ 3rd,etc.Correlates of osteoprotegerin levels in women and men.[J].2002,13(5).
- [5]Skoumal M,Woloszczuk W,Hawa G,etc.Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.[J].2005,26(1).
- [6]Bucay N.,Sarosi I.,Dunstan C. R.,etc.Osteoprotegerin-Deficient Mice Develop Early Onset Osteoporosis and Arterial\u00a0calcification[J].1998.
- [7]A, Glinka,W, Wu,H, Delius,etc.Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction.[J].1998,391(6665).
- [8]Goldring MB,Goldring SR.Eating bone or adding it: the Wnt pathway decides.[J].2007,13(2).
- [9]Y Y, Kong,U, Feige,I, Sarosi,etc.Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.[J].1999,402.
- [10]Bryant HU,Macdougald OA,Krishnan V.Regulation of bone mass by Wnt signaling.[J].2006,116(5).
- [11]Liossis,S.-N.C.,Andonopoulos,A.P.,Solomou,E.E.,etc.Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis[J].2010,62(1).
- [12]Long FX,Patel MS,Taketo MM,etc.Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation[J].2005,8(5).
- [13]Diarra D,Ominsky MS,Korb A,etc.Dickkopf-1 is a master regulator of joint remodeling.[J].2007,13(2).
- [14]Yaniv A,Liu G,Gazit A,etc.Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.[J].2001,3(7).
- [15]Haynes DR,Crotti TN,Loric M,etc.Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.[J].2001,40(6).
- [16]Prevoo ML,van 't Hof MA,Kuper HH,etc.Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.[J].1995,38(1).
- [17]Khosla S,Kostenuik PJ,Kearns AE.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.[J].2008,29(2).
- [18]Tabassi NC,Garnero P,Voorzanger-Rousselot N.Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept.[J].2008,35(12).
- [19]van der-Heijde-D.How to read radiographs according to the Sharp/van der Heijde method (corrected and republished article originally printed in J Rheumatol 1999 Mar; 26(3):743-5)[J].2000,27(1).
- [20]Kojima H,Kobata T,Kanno Y,etc.Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.[J].2008,58(11).